National Center for Advancing Translational Sciences; Notice of Closed Meetings, 22701 [2018-10471]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 95 / Wednesday, May 16, 2018 / Notices
Democracy Blvd., Suite 920, Bethesda, MD
20892, (301) 496–8775, john.holden@nih.gov.
Dated: May 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10473 Filed 5–15–18; 8:45 am]
BILLING CODE 4140–01–P
Health, 6701 Democracy Blvd, Democracy 1,
Room 1080, Bethesda, MD 20892–4874
chenjing@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: May 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2018–10471 Filed 5–15–18; 8:45 am]
National Center for Advancing
Translational Sciences; Notice of
Closed Meetings
BILLING CODE 4140–01–P
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; CTSA Collaborative
Innovation Award Review.
Date: June 20–21, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1068, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: M. Lourdes Ponce, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd,
Democracy 1, Room 1073 Bethesda, MD
20892, 301–435–0810, lourdes.ponce@
nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; Platform Delivery
Technologies for Nucleic Acid Therapeutics.
Date: June 26–27, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, Room 1080, 6701
Democracy Boulevard, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Jing Chen, Ph.D., Scientific
Review Officer, Office of Scientific Review,
National Center for Advancing Translational
Sciences (NCATS), National Institutes of
VerDate Sep<11>2014
17:34 May 15, 2018
Jkt 244001
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID: FEMA–2018–0011; OMB No.
1660—NEW]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; Post
Disaster Survivor Preparedness
Research
Federal Emergency
Management Agency, DHS.
ACTION: Notice and request for
comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA) will
submit the information collection
abstracted below to the Office of
Management and Budget for review and
clearance in accordance with the
requirements of the Paperwork
Reduction Act of 1995. The submission
will describe the nature of the
information collection, the categories of
respondents, the estimated burden (i.e.,
the time, effort and resources used by
respondents to respond) and cost, and
the actual data collection instruments
FEMA will use.
DATES: Comments must be submitted on
or before June 15, 2018.
ADDRESSES: Submit written comments
on the proposed information collection
to the Office of Information and
Regulatory Affairs, Office of
Management and Budget. Comments
should be addressed to the Desk Officer
for the Department of Homeland
Security, Federal Emergency
Management Agency, and sent via
electronic mail to dhsdeskofficer@
omb.eop.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
copies of the information collection
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
22701
should be made to Director, Information
Management Division, 500 C Street SW,
Washington, DC 20472, email address
FEMA-Information-CollectionsManagement@fema.dhs.gov or
Jacqueline Snelling, Senior Advisor,
U.S. Department of Homeland Security/
FEMA/National Preparedness
Directorate, Individual and Community
Preparedness Division, Washington, DC
20472–3630, jacqueline.snelling@
fema.dhs.gov.
SUPPLEMENTARY INFORMATION: This
proposed information collection
previously published in the Federal
Register on February 14, 2018 at 83 FR
6611 with a 60 day public comment
period. FEMA received 14 anonymous
public comments that were not relevant
to the information collection. FEMA
noticed a mistake in the number of
respondents that results in a change
from what was published on February
14, 2018, at 83 FR 6611. The number of
respondents has changed from 3,120 to
6,120. FEMA also noted a mistake in the
total annual respondent cost from
$19,240.00 to $26,299.60. The purpose
of this notice is to notify the public that
FEMA will submit the information
collection abstracted below to the Office
of Management and Budget for review
and clearance.
Collection of Information
Title: Post Disaster Survivor
Preparedness Research.
Type of Information Collection: New
information collection.
OMB Number: 1660—NEW.
Form Titles and Numbers: FEMA
Form 519–0–54, Post Disaster Survivor
Preparedness Research.
Abstract: Through improved
understanding of the relationship
between an individual’s preparedness
knowledge, actions, and perception and
self-efficacy, FEMA will be able to draw
some conclusions as to how these
factors contribute to and/or hinder lifesaving responses and short and longterm recovery, with a focus on
historically underserved communities.
Affected Public: Individuals or
households.
Estimated Number of Respondents:
6,120.
Estimated Number of Responses:
6,120.
Estimated Total Annual Burden
Hours: 740.
Estimated Total Annual Respondent
Cost: $26,299.60
Estimated Respondents’ Operation
and Maintenance Costs: $0.
Estimated Respondents’ Capital and
Start-Up Costs: $0.
Estimated Total Annual Cost to the
Federal Government: $186,573.45.
E:\FR\FM\16MYN1.SGM
16MYN1
]]>Agencies
[Federal Register Volume 83, Number 95 (Wednesday, May 16, 2018)]
[Notices]
[Page 22701]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10471]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; CTSA Collaborative Innovation Award
Review.
Date: June 20-21, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, Room
1068, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: M. Lourdes Ponce, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Center for Advancing
Translational Sciences (NCATS), National Institutes of Health, 6701
Democracy Blvd, Democracy 1, Room 1073 Bethesda, MD 20892, 301-435-
0810, [email protected].
Name of Committee: National Center for Advancing Translational
Sciences Special Emphasis Panel; Platform Delivery Technologies for
Nucleic Acid Therapeutics.
Date: June 26-27, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, One Democracy Plaza, Room
1080, 6701 Democracy Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Jing Chen, Ph.D., Scientific Review Officer,
Office of Scientific Review, National Center for Advancing
Translational Sciences (NCATS), National Institutes of Health, 6701
Democracy Blvd, Democracy 1, Room 1080, Bethesda, MD 20892-4874
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research; 93.350,
B--Cooperative Agreements; 93.859, Biomedical Research and Research
Training, National Institutes of Health, HHS)
Dated: May 10, 2018.
David D. Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10471 Filed 5-15-18; 8:45 am]
BILLING CODE 4140-01-P
